Workflow
Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Indivior PLC is one of them. Indivior PLC (NASDAQ:INDV) is a pharmaceutical company specializing in treatments for opioid use disorder (OUD), with its core products SUBLOCADE, a once-monthly buprenorphine injection, and SUBOXONE film forming the backbone of its revenue. In September 2025, the corporation reported strong Q2 results, with total net revenue of 302million.SUBLOCADEsalesrose9302 million. SUBLOCADE sales rose 9% year-over-year to 20 ...